Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
10/2002
10/31/2002US20020161212 BPC-1: a secreted brain-specific protein expressed and secreted by prostate and bladder cancer cells
10/31/2002US20020161201 For use in cancer diagnosis and therapy
10/31/2002US20020161200 For therapy
10/31/2002US20020161196 Trail receptors nucleic acids encoding the same and methods of use thereof
10/31/2002US20020161195 Trail receptors, nucleic acids encoding the same, and methods of use thereof
10/31/2002US20020161193 Useful for the production of NMDA receptor subunit proteins, these nucleic acids are also useful as probes, to identify and isolate related human receptor subunits
10/31/2002US20020161191 Novel Imidazoline receptor homologs
10/31/2002US20020161188 Utilization of mass spectroscopy to elucidate particular biopolymer markers indicative of disease state; biopolymer sequences having a unique relationship to at least one particular disease state
10/31/2002US20020161187 Biopolymer marker indicative of disease state having a molecular weight of 1097 daltons
10/31/2002US20020161186 Biopolymer marker indicative of disease state having a molecular weight of 1449 daltons
10/31/2002US20020161185 Utilization of mass spectroscopy to elucidate particular biopolymer markers indicative of disease state; biopolymer sequences having a unique relationship to at least one particular disease state
10/31/2002US20020161184 Biopolymer marker indicative of disease state having a molecular weight of 1348 daltons
10/31/2002US20020161183 Biopolymer marker indicative of disease state having a molecular weight of 2267 daltons
10/31/2002US20020161182 Utilization of mass spectroscopy to elucidate particular biopolymer markers indicative of disease state; biopolymer sequences having a unique relationship to at least one particular disease state
10/31/2002US20020161181 Biopolymer marker indicative of disease state having a molecular weight of 2021 daltons
10/31/2002US20020161180 Biopolymer marker indicative of disease state having a molecular weight of 1896 daltons
10/31/2002US20020161179 Utilization of mass spectroscopy to elucidate particular biopolymer markers indicative of disease state; biopolymer sequences having a unique relationship to one particular disease state
10/31/2002US20020161177 Utilization of mass spectroscopy to elucidate particular biopolymer markers indicative of disease state; biopolymer sequences having a unique relationship to at least one particular disease state
10/31/2002US20020161009 Use of selective antagonists of the alpha1b-adrenergic receptor for improvement of sexual dysfunction
10/31/2002US20020160980 Method of treating hepatitis delta virus infection
10/31/2002US20020160978 Inhibitors of spermidine synthase for the treatment of osteoarthritis and cartilage rehabilitation
10/31/2002US20020160974 Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays
10/31/2002US20020160968 Inhibitor of niacinamide phosphoribosyl transferase (NAPRT)
10/31/2002US20020160964 Conjugates comprising galactose alpha 1,3 galactosyl epitopes and methods of using same
10/31/2002US20020160958 Polypeptide of sequence ID DAHKSEVAHRFKD; indicates renal failure
10/31/2002US20020160957 Treating tumors
10/31/2002US20020160948 Such as preventing or treating primary cancer cell growth
10/31/2002US20020160939 Method of identification of inhibitors of PDE1C and methods of treatment of diabetes
10/31/2002US20020160936 Hepatitis C virus envelope E2 protein (HCV E2); inhibiting the attachment of hepatitis C virus onto cells
10/31/2002US20020160933 Methods and compositions for producing a neurosalutary effect in a subject
10/31/2002US20020160538 Assay device
10/31/2002US20020160537 Method of detecting cardiac ischemia using fatty acid binding protein
10/31/2002US20020160535 Analyzing samples for particular substances by means of fluorescent binding assays, using evanescent light
10/31/2002US20020160534 Waveguide immunosensor with coating chemistry and providing enhanced sensitivity
10/31/2002US20020160533 Biopolymer marker indicative of disease state having a molecular of weight of 1525 daltons
10/31/2002US20020160532 Biopolymer marker indicative of disease state having a molecular weight of 1998 daltons
10/31/2002US20020160531 Biopolymer marker indicative of disease state having a molecular weight of 2753 daltons
10/31/2002US20020160530 Method of transferring molecules to a coated film laminate having an ionic surface
10/31/2002US20020160529 Utilization of mass spectroscopy to elucidate particular biopolymer markers indicative of disease state; specific biopolymer sequences having a unique relationship to a eparticular disease state
10/31/2002US20020160528 Biopolymer marker indicative of disease state having a molecular weight of 1350 daltons
10/31/2002US20020160526 Target biological material being placed in contact with capture phase, and capture phase/target biological material complex is detected; capture phase is in microparticulate or linear form and consists of particle or polymer
10/31/2002US20020160525 Immunoassay devices and materials
10/31/2002US20020160524 Sample is contacted with receptor molecule having binding sites for analyte and labelled with marker, back-titrated using second marker; measuring signals to provide value representative of fractional occupancy of the binding
10/31/2002US20020160523 Method for monitoring resting and activated platelets in unfixed blood samples
10/31/2002US20020160520 For collecting and analyzing small volumes of fluid for analysis
10/31/2002US20020160519 Obtaining serum; obtaining a reaction mixture of an acrylating compound and perchlorate ion; reacting to produce colored product; measuring spectral data for colored product; applying multiple wavelength detectiion with statistical analysis
10/31/2002US20020160517 Distinguishing test types through spectral analysis
10/31/2002US20020160505 Modulation of cellular adhesion with lipid membrane micro-arrays
10/31/2002US20020160497 For use in detection and treatment of the disease, breast cancer, prostate cancer, testicular cancer, ovarian cancer, uterine cancer cervical cancer, and colon cancer
10/31/2002US20020160493 Serine/threonine phosphatase polynucleotides, polypeptides, and antibodies
10/31/2002US20020160490 For screening physiologically active substances using serine protease or DNA that codes for it
10/31/2002US20020160485 Polynucleotide motor, a motor system, their preparation and uses
10/31/2002US20020160481 Isolated human dehydrogenases, nucleic acid molecules encoding these human dehydrogenases, and uses thereof
10/31/2002US20020160478 Short peptides which selectively modulate the activity of protein kinases
10/31/2002US20020160472 Coupling drug to glycidyl methacrylate-styrene copolymer
10/31/2002US20020160470 Methods and apparatus for generating and utilizing linear moving optical gradients
10/31/2002US20020160463 Phagemid for antibody screening
10/31/2002US20020160448 Human c-Maf compositions and methods of use thereof
10/31/2002US20020160447 Ups (ugc)
10/31/2002US20020160443 Method and apparatus for computer controlled rare cell, including fetal cell, based diagnosis
10/31/2002US20020160442 Quantitative analysis
10/31/2002US20020160438 Modulate kinase; antiinflammatory agents; respiratory system disorders
10/31/2002US20020160435 Immunoassay for measuring human C-peptide and kit therefor
10/31/2002US20020160434 Polypeptides; medical diagnosis
10/31/2002US20020160433 Diagnosis of urogenital disorders
10/31/2002US20020160432 Quantitative analysis; diagnosis of infections
10/31/2002US20020160429 Using antibody released by hybridomas cells
10/31/2002US20020160428 Quantitative non-instrumental immunoassay and device using coloured particles
10/31/2002US20020160427 Methods and apparatuses for electronic determination of analytes
10/31/2002US20020160426 Using drops; storage; crystallization; detection of images
10/31/2002US20020160425 Process for differential diagnosis of Alzheimer's dementia and device therefor
10/31/2002US20020160424 T1R hetero-oligomeric taste receptors
10/31/2002US20020160423 Polypeptides; medical diagnosis
10/31/2002US20020160422 Polypeptides; medical diagnosis
10/31/2002US20020160421 Method for monitoring and validating stress induction of disease state
10/31/2002US20020160420 Process for diagnosis of physiological conditions by characterization of proteomic materials
10/31/2002US20020160419 Biopolymer marker indicative of disease state having a molecular weight of 1793 daltons
10/31/2002US20020160418 Biopolymer marker indicative of disease state having a molecular weight of 1949 daltons
10/31/2002US20020160417 Biopolymer marker indicative of disease state having a molecular weight of 1424 daltons
10/31/2002US20020160415 Methods, pharmaceutical formulations and kits for identification of subjects at risk for cancer and for the prevention of cancer in at- risk subjects
10/31/2002US20020160413 Complexes; amplification
10/31/2002US20020160412 Inventory control
10/31/2002US20020160408 Detection interaction between proteins
10/31/2002US20020160402 Linear and circular expression elements
10/31/2002US20020160400 Radiative decay engineering
10/31/2002US20020160395 Detection of survivin in the biological fluids of cancer patients
10/31/2002US20020160394 Regulation of transthyretin to treat obesity
10/31/2002US20020160392 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/31/2002US20020160391 Reversible binding of molecules to metal substrates through affinity interactions
10/31/2002US20020160390 Polymorphic DNAs and their use for diagnosis of susceptibility to panic disorder
10/31/2002US20020160387 Compositions and methods relating to ovary specific genes and proteins
10/31/2002US20020160386 Methods of using transporter-like molecules to treat pain and pain-related disorders
10/31/2002US20020160384 Polypeptides; binding to antibodies
10/31/2002US20020160382 Detection cell differentiation gene expression
10/31/2002US20020160374 Fusion protein; genetic engineering; binding to antibodies
10/31/2002US20020160367 Coated film laminate having an ionic surface
10/31/2002US20020160365 Compositions and methods for the early diagnosis of ovarian cancer
10/31/2002US20020160363 Magnetic-based placement and retention of sensor elements in a sensor array
10/31/2002US20020160362 Measurement variations of allele polypeptides gene; diagnosis of arthritis, cancer
10/31/2002US20020160360 Hybrid analysis; target binding efficiency
1 ... 2720 2721 2722 2723 2724 2725 2726 2727 2728 2729 2730 2731 2732 2733 2734 2735 2736 2737 2738 2739 2740 ... 3937